ACROMEGALY
Clinical trials for ACROMEGALY explained in plain language.
Never miss a new study
Get alerted when new ACROMEGALY trials appear
Sign up with your email to follow new studies for ACROMEGALY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended trial tests pill for rare hormone disorder
Disease control OngoingThis study follows patients who previously participated in earlier trials of paltusotine, an oral medication for acromegaly. Researchers want to understand the long-term safety and effectiveness of continued treatment. The study tracks side effects and measures hormone levels ove…
Matched conditions: ACROMEGALY
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 02, 2026 01:56 UTC
-
Pill vs. injection: new hope for acromegaly control
Disease control OngoingThis study is testing if a daily pill called paltusotine can safely maintain control of acromegaly in people who are already stable on standard injectable treatments. About 58 adults will be randomly assigned to either keep taking the pill or switch to a placebo (inactive pill) f…
Matched conditions: ACROMEGALY
Phase: PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New pill tested to control rare hormone disorder
Disease control OngoingThis study is testing whether a new oral medication called paltusotine can safely control the hormone levels and symptoms of acromegaly. It involves 111 adults with acromegaly who are not currently on other drug treatments. Participants are randomly assigned to receive either the…
Matched conditions: ACROMEGALY
Phase: PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC